Andrew Katims
Papers
6
Total Citations
103
H-Index
5
About
Andrew Katims is a urologic oncologist whose research focuses on improving surgical outcomes for patients with upper tract urothelial carcinoma (UTUC) and bladder cancer. His work centers on refining minimally invasive techniques—particularly robot-assisted radical cystectomy (RARC) and nephroureterectomy—to reduce recurrence and enhance recovery. As a key contributor to the multi-institutional ROBUUST Collaboration, Katims led a landmark study identifying risk factors for intravesical recurrence after minimally invasive nephroureterectomy for UTUC, a critical issue given recurrence rates of 20-50%. His research also explores how perioperative factors, such as anesthetic type (volatile vs. total intravenous) and opioid-sparing protocols, can influence oncologic outcomes and recovery after radical cystectomy. With over 100 citations across his most-cited works, Katims has helped shift practice toward evidence-based, patient-centered care. Notably, his 2021 review on RARC versus open cystectomy clarifies what is known—and what remains uncertain—about these approaches, providing essential guidance for surgeons. His work on increasing utilization of perioperative intravesical chemotherapy during nephroureterectomy highlights his commitment to translating research into tangible improvements in clinical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6